Cancer Genetics Unit, Hormones & Cancer Group, Kolling Institute of Medical Research, University of Sydney, Sydney, Australia.
Mol Cell Endocrinol. 2012 Mar 31;351(1):118-28. doi: 10.1016/j.mce.2011.09.041. Epub 2011 Oct 2.
MicroRNAs (miRNAs) are short non-coding RNAs that are involved in the epigenetic regulation of cellular processes. Different malignancies are often associated with the deregulation of specific sets of miRNAs. The prognosis of adrenocortical cancers (ACCs) is very poor as compared to adrenocortical adenomas (ACAs), and even within ACCs there are cases with better disease specific survival. An improved understanding of the pathobiology of this disease will therefore be useful in facilitating better management of ACCs as well as distinguishing high risk versus low risk subgroups. One third of coding genes are regulated by miRNAs and therefore changes in miRNA expression may be associated with cancer development and progression. In this review we summarize the current understanding of miRNAs in adrenocortical tumors, and highlight their potential in differentiating between ACCs and ACAs, risk stratification and prognosis.
MicroRNAs (miRNAs) 是短的非编码 RNA,参与细胞过程的表观遗传调控。不同的恶性肿瘤通常与特定 miRNA 集的失调有关。与肾上腺皮质腺瘤 (ACAs) 相比,肾上腺皮质癌 (ACCs) 的预后非常差,即使在 ACCs 中,也有一些病例具有更好的疾病特异性生存。因此,更好地了解这种疾病的病理生物学将有助于更好地管理 ACCs,并区分高危与低危亚组。三分之一的编码基因受到 miRNA 的调控,因此 miRNA 表达的变化可能与癌症的发生和发展有关。在这篇综述中,我们总结了 miRNA 在肾上腺皮质肿瘤中的最新认识,并强调了它们在区分 ACCs 和 ACAs、风险分层和预后方面的潜在应用。